The Clinical Efficacy and Safety of Finerenone in the Treatment of Primary Aldosteronism

Conditions: Primary Aldosteronism; Finerenone; Mineralocorticoid Receptor Antagonist Interventions: Drug: Finerenone Sponsors: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Recruiting

https://clinicaltrials.gov/study/NCT06381323

Source: ClinicalTrials.gov - April 24, 2024 Category: Research Source Type: clinical trials

More News: Hospitals | Research